SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-016223
Filing Date
2024-05-13
Accepted
2024-05-13 16:03:43
Documents
15
Period of Report
2024-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20240305_8k.htm   iXBRL 8-K 30280
2 EXHIBIT 99.1_ITEM 2.02 FINANCIAL RESULTS ex_634999.htm EX-99.1 82087
  Complete submission text file 0001437749-24-016223.txt   255594

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20240513.xsd EX-101.SCH 3408
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20240513_def.xml EX-101.DEF 11423
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20240513_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20240513_pre.xml EX-101.PRE 11583
18 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20240305_8k_htm.xml XML 2853
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 24938926
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)